These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 10959773)

  • 21. Pharmacogenetics, pharmacogenomics, and cardiovascular therapeutics: the way forward.
    Terra SG; Johnson JA
    Am J Cardiovasc Drugs; 2002; 2(5):287-96. PubMed ID: 14727958
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacogenetics and adverse drug reactions.
    Meyer UA
    Lancet; 2000 Nov; 356(9242):1667-71. PubMed ID: 11089838
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Progressing the utilisation of pharmacogenetics and pharmacogenomics into clinical care.
    Trent RJ; Cheong PL; Chua EW; Kennedy MA
    Pathology; 2013 Jun; 45(4):357-70. PubMed ID: 23594690
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prediction of drug response and adverse drug reactions: From twin studies to Next Generation Sequencing.
    Lauschke VM; Ingelman-Sundberg M
    Eur J Pharm Sci; 2019 Mar; 130():65-77. PubMed ID: 30684656
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genotyping of drug targets: a method to predict adverse drug reactions?
    Güzey C; Spigset O
    Drug Saf; 2002; 25(8):553-60. PubMed ID: 12113641
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genome-wide association study: a useful tool to identify common genetic variants associated with drug toxicity and efficacy in cancer pharmacogenomics.
    Low SK; Takahashi A; Mushiroda T; Kubo M
    Clin Cancer Res; 2014 May; 20(10):2541-52. PubMed ID: 24831277
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacogenetics and pharmacogenomics: development, science, and translation.
    Weinshilboum RM; Wang L
    Annu Rev Genomics Hum Genet; 2006; 7():223-45. PubMed ID: 16948615
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Falls: the adverse drug reaction of the elderly and the impact of pharmacogenetics.
    Just KS; Schneider KL; Schurig M; Stingl JC; Brockmöller J
    Pharmacogenomics; 2017 Aug; 18(13):1281-1297. PubMed ID: 28776468
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacogenetics for severe adverse drug reactions induced by molecular-targeted therapy.
    Udagawa C; Zembutsu H
    Cancer Sci; 2020 Oct; 111(10):3445-3457. PubMed ID: 32780457
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacogenomics and its potential impact on drug and formulation development.
    Regnstrom K; Burgess DJ
    Crit Rev Ther Drug Carrier Syst; 2005; 22(5):465-92. PubMed ID: 16313234
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adverse Drug Reactions to Anti-TB Drugs: Pharmacogenomics Perspective for Identification of Host Genetic Markers.
    Sahu RK; Singh K; Subodh S
    Curr Drug Metab; 2015; 16(7):538-52. PubMed ID: 26264201
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Drug therapy and pharmacogenomics--hopes and facts].
    Müller-Zellenberg U; Müller M
    Wien Med Wochenschr; 2005 Feb; 155(3-4):45-9. PubMed ID: 15791775
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of cost-effectiveness analysis in the era of pharmacogenomics.
    Flowers CR; Veenstra D
    Pharmacoeconomics; 2004; 22(8):481-93. PubMed ID: 15217305
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Report on the pharmacogenomics and personalized medicine 2011 conference: part 1.
    Harrison N
    Pharmacogenomics; 2012 Jan; 13(2):141-5. PubMed ID: 22256866
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genomic technology applied to pharmacological traits.
    Yang JJ; Plenge RM
    JAMA; 2011 Aug; 306(6):652-3. PubMed ID: 21828330
    [No Abstract]   [Full Text] [Related]  

  • 36. Pharmacogenomics of adverse drug reactions: practical applications and perspectives.
    Becquemont L
    Pharmacogenomics; 2009 Jun; 10(6):961-9. PubMed ID: 19530963
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Personalized pharmacogenomics: predicting efficacy and adverse drug reactions.
    Pirmohamed M
    Annu Rev Genomics Hum Genet; 2014; 15():349-70. PubMed ID: 24898040
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Advances in the Pharmacogenomics of Adverse Drug Reactions.
    Collins SL; Carr DF; Pirmohamed M
    Drug Saf; 2016 Jan; 39(1):15-27. PubMed ID: 26650062
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Progress and Challenges in Pharmacogenomics.
    Van Driest SL; Cascorbi I
    Clin Pharmacol Ther; 2021 Sep; 110(3):529-532. PubMed ID: 34412159
    [No Abstract]   [Full Text] [Related]  

  • 40. Pharmacogenomics: paving the path to personalized medicine.
    Patrinos GP; Innocenti F
    Pharmacogenomics; 2010 Feb; 11(2):141-6. PubMed ID: 20136354
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.